Exosome RNA Exosome RNA Research & Industry News
Understanding how cancer spreads and behaves at a molecular level is key to advancing diagnostics and treatment. A new study led by researchers from Cedars-Sinai Medical Center explores a particularly intriguing type of extracellular vesicle (EV) called large oncosomes (LOs). These are abnormally large vesicles shed by aggressive cancer cells that carry a rich mix of proteins and genetic material.
Unlike typical exosomes, LOs are bigger and less well-understood. To address this gap, the research team optimized a method to isolate these vesicles more efficiently and applied advanced tools like mass spectrometry and RNA sequencing to analyze their molecular contents. They discovered a consistent group of proteins present in LOs derived from prostate, breast, and glioma cancer cell lines—indicating a possible shared signature among various aggressive tumors.
What’s more, these same proteins, along with their messenger RNAs, were found in LOs taken from the blood plasma of 20 patients with metastatic prostate cancer. The researchers even used single-vesicle RNA sequencing to confirm that individual LOs carry the same markers found in the larger group—showing how powerful single-cell techniques can be for analyzing these large vesicles.
This comprehensive profiling reveals that LOs are not just cellular debris; they may play a critical role in cancer communication and progression. The findings suggest that LOs could help doctors better classify patients with advanced disease, pointing toward a future where a simple blood test could inform cancer diagnosis and prognosis more precisely. It’s a promising step toward integrating multi-analyte liquid biopsies into clinical practice.
